New drug combo tested against standard therapy in Hard-to-Treat myeloma
Disease control
Ongoing
This phase 3 trial tests whether a combination of selinexor, pomalidomide, and dexamethasone works better than elotuzumab, pomalidomide, and dexamethasone for people with multiple myeloma that has come back or stopped responding to treatment. About 117 participants who have alrea…
Phase: PHASE3 • Sponsor: European Myeloma Network B.V. • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC